These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
18. Inhibition of IFN-gamma-mediated inducible nitric oxide synthase induction by the peroxisome proliferator-activated receptor gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway. Chen CW; Chang YH; Tsi CJ; Lin WW J Immunol; 2003 Jul; 171(2):979-88. PubMed ID: 12847270 [TBL] [Abstract][Full Text] [Related]
19. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in rat aortic smooth muscle cells. Iijima K; Yoshizumi M; Ako J; Eto M; Kim S; Hashimoto M; Sugimoto N; Liang YQ; Sudoh N; Toba K; Ouchi Y Biochem Biophys Res Commun; 1998 Jun; 247(2):353-6. PubMed ID: 9642130 [TBL] [Abstract][Full Text] [Related]
20. An anti-ulcer drug, geranylgeranylacetone, suppresses inducible nitric oxide synthase in cultured vascular smooth muscle cells. Yamamoto K; Sarukawa M; Ito T; Aoki H; Ichida M; Shimada K J Hypertens; 2005 Oct; 23(10):1847-53. PubMed ID: 16148608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]